ARG Collaborating with Cytokinetics on the COURAGE-ALS Trial of Reldesemtiv
Our partner Cytokinetics, Incorporated announced August 2, 2021 that COURAGE-ALS, a Phase 3 clinical trial of Reldesemtiv in patients with ALS, is open to enrollment.
Xtalks Webinar: ALS Biomarkers in Drug Development
Atlantic Research Group will be presenting a webinar via Xtalks on Tuesday, June 22, 2021 at 11am EST. Please register here. Webinar Content Description: Amyotrophic…
BPL And Atlantic Research Group Enter Into Long-term Collaboration
28 April, 2021–Bio Products Laboratory (BPL), a leading manufacturer of plasma-derived protein therapies headquartered in Elstree, UK, today announced the signing of a collaboration agreement…
Identifying Critical Success Factors In Retrospective Studies
Retrospective studies look back through time using existing records to examine safety, clinical, and (healthcare) utilization data.
Atlantic Research Group Supports Rare Disease Day: Sunday, February 28, 2021
Rare Disease Day is Sunday, February 28, 2021. Atlantic Research Group is proud to support rare disease clinical trials, advocacy groups, and most importantly, patients…